Content about Collis

September 21, 2012
AmerisourceBergen: Pharmaceuticals business has bright future

The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said at the wholesaler's ThinkLive Manufacturer's Summit.

PHILADELPHIA — The pharmaceuticals business will begin picking up in 2014, AmerisourceBergen president and CEO Steve Collis said last week at the wholesaler's ThinkLive Manufacturer's Summit held here. "Next year is a slower brand-to-generic [trend] and in 2014 we’re going to see a resumption in that top-line growth rate [across the pharmaceutical industry in the U.S.] to a modest 4% growth," Collis said. "That’s not too bad," he added, especially when you compare that growth up against what's happening worldwide.

July 5, 2011
Collis succeeds Yost as CEO of AmerisourceBergen

David Yost officially handed the reins of AmerisourceBergen to Steven Collis, who was named president and CEO on Friday, as Yost prepares for retirement.

VALLEY FORGE, Pa. — David Yost officially handed the reins of AmerisourceBergen to Steven Collis, who was named president and CEO on Friday, as Yost prepares for retirement.

April 4, 2011
David Neu named ABDC president

AmerisourceBergen on Monday promoted David Neu, 53, to president of AmerisourceBergen Drug, the company's largest operating unit, effective immediately. Neu, a 29-year veteran of the company, most recently was SVP operations.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday promoted David Neu, 53, to president of AmerisourceBergen Drug, the company's largest operating unit, effective immediately. Neu, a 29-year veteran of the company, most recently was SVP operations.

The role of president of AmerisourceBergen Drug previously was held by Steven Collis, currently EVP and COO. Collis recently was named to succeed David Yost as CEO upon Yost's retirement on July 1. In his new role, Neu will continue to report to Steven Collis.

March 14, 2011
Yost leaves helm of AmerisourceBergen

AmerisourceBergen Monday afternoon announced that CEO David Yost will retire from the wholesaler, effective July 1, after 37 years with the company and the last 14 as CEO.

VALLEY FORGE, Pa. — AmerisourceBergen Monday afternoon announced that CEO David Yost will retire from the wholesaler, effective July 1, after 37 years with the company and the last 14 as CEO.

Yost will be succeeded by Steven Collis, 49.

November 11, 2010
AmerisourceBergen names new president, COO

Pharmaceutical services company AmerisourceBergen has appointed Steve Collis as president and COO, the company said...

VALLEY FORGE, Pa. Pharmaceutical services company AmerisourceBergen has appointed Steve Collis as president and COO, the company said Friday.

 

Collis previously served as EVP of AmerisourceBergen and as president of AmerisourceBergen Drug Corp., serving as president of AmerisourceBergen Specialty Group before that. He will report directly to CEO R. David Yost and will be responsible for business units, such as ABDC, ABSG, AmerisourceBergen Consulting Services and AmerisourceBergen Packaging Group.